DraftKings (DKNG) Stock Forecast & Price Target

Q: What analysts cover DraftKings?

DraftKings has been rated by research analysts at Barclays , Benchmark , BNP Paribas Exane , BTIG Research , Citigroup , Citizens Jmp , Deutsche Bank Aktiengesellschaft , Freedom Capital , Guggenheim , HSBC , Jefferies Financial Group , JPMorgan Chase & Co. , Mizuho , Moffett Nathanson , Morgan Stanley , Needham & Company LLC , New Street Research , Northland Securities , Raymond James Financial , Roth Mkm , Sanford C. Bernstein , Scotiabank , Stephens , Susquehanna , TD Cowen , Truist Financial , UBS Group , Wedbush , Weiss Ratings , Wells Fargo & Company , and Zacks Research in the past 90 days.

$25.89 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$25.90 +0.01 (+0.04%)

As of 09:22 AM Eastern

Compare

DraftKings - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 40 Analyst Ratings

Sell
2

Hold
8

Buy
30

Based on 40 Wall Street analysts who have issued ratings for DraftKings in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 40 analysts, 2 have given a sell rating, 8 have given a hold rating, 29 have given a buy rating, and 1 has given a strong buy rating for DKNG.

Consensus Price Target

$34.24
32.25% Upside

According to the 40 analysts' twelve-month price targets for DraftKings, the average price target is $34.24. The highest price target for DKNG is $50.00, while the lowest price target for DKNG is $20.00. The average price target represents a forecasted upside of 32.25% from the current price of $25.89.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for DKNG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for DraftKings and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DKNG Analyst Ratings Over Time

Type	Current Forecast 7/6/25 to 7/6/26	1 Month Ago 6/6/25 to 6/6/26	3 Months Ago 4/7/25 to 4/7/26	1 Year Ago 7/6/24 to 7/6/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	29 Buy rating(s)	27 Buy rating(s)	25 Buy rating(s)	26 Buy rating(s)
Hold	8 Hold rating(s)	9 Hold rating(s)	5 Hold rating(s)	1 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$34.24	$34.35	$36.23	$53.90
Forecasted Upside	32.25% Upside	37.77% Upside	57.86% Upside	32.51% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

DKNG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DKNG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

DraftKings Stock vs. The Competition

Type	DraftKings	Consumer Discretionary Companies	Broader Market
Consensus Rating Score	2.73	2.11	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	32.25% Upside	93.92% Upside	13.30% Upside
News Sentiment Rating	Positive News See Recent DKNG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/1/2026	Susquehanna 5 of 5 stars	Joseph Stauff 4 of 5 stars	Lower Target	Positive	$32.00 ➝ $31.00	+22.72%
6/25/2026	Citizens Jmp 4 of 5 stars	Jordan Bender 2 of 5 stars	Boost Target	Market Outperform	$34.00 ➝ $36.00	+50.98%
6/24/2026	Guggenheim 5 of 5 stars	Vamil Divan 5 of 5 stars	Reiterated Rating	Buy	$35.00	+39.16%
6/22/2026	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
6/22/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
6/11/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
6/10/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
6/8/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Vitanza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$30.00	+20.66%
6/5/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$43.00 ➝ $49.00	+92.88%
6/1/2026	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$29.00	+9.83%
Get the Latest News and Ratings for DKNG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for DraftKings and its competitors with MarketBeat's FREE daily newsletter.
5/21/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ed Young Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
5/20/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
5/20/2026	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
5/14/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Neutral ➝ Underperform	$20.00	-20.10%
5/12/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Chaiken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$44.00 ➝ $45.00	+83.60%
5/11/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Sell (D+) ➝ Sell (D)
5/11/2026	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$27.00	+10.86%
5/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandt Montour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$33.00 ➝ $35.00	+37.15%
5/11/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$35.00	+37.15%
5/10/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trey Bowers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$32.00	+25.39%
5/8/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Lampen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$28.00 ➝ $30.00	+18.95%
4/24/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Equal Weight ➝ Overweight
4/24/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Outperform
4/24/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform
4/24/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold
4/24/2026	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell ➝ Buy
4/24/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold
4/24/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Neutral ➝ Outperform
4/24/2026	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Fishman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$38.00 ➝ $27.00	+21.79%
4/21/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barry Jonas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$33.00 ➝ $30.00	+28.29%
4/16/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Politzer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$32.00 ➝ $31.00	+30.72%
3/17/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Eade Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
3/3/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Pitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$42.00 ➝ $50.00	+110.12%
2/24/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Cummins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$26.40	+18.51%
2/17/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Stantial Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$44.00 ➝ $40.00	+85.54%
2/17/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$54.00 ➝ $31.00	+37.93%
2/17/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jed Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$50.00 ➝ $35.00	+60.85%
2/13/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Graham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$50.00 ➝ $44.00	+74.88%
2/13/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shaun Kelley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$37.50 ➝ $30.00	+19.24%
1/30/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$35.00	+23.74%
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open
1/8/2026	Texas Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold
11/10/2025	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chad Beynon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$50.00 ➝ $48.00	+54.53%
4/24/2025	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Vitanza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$60.00 ➝ $55.00	+59.50%
4/14/2025	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Warring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Moderate Buy
2/18/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Farrell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$48.00 ➝ $60.00	+13.59%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 09:24 AM ET.

Should I Buy DraftKings Stock? DKNG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, July 5, 2026. Please send any questions or comments about these DraftKings pros and cons to contact@marketbeat.com.

DraftKings
Bull Case

Here are some ways that investors could benefit from investing in DraftKings Inc.:

DraftKings Inc. is a leading player in the digital sports entertainment and gaming industry, specializing in daily fantasy sports and sports betting, which are rapidly growing markets.
The company has a strong technological foundation that supports real-time odds and advanced analytics, enhancing user experience and engagement across its platforms.
Recent insider trading activity indicates confidence in the company's future, with significant transactions executed under pre-arranged trading plans, suggesting that insiders believe in the long-term value of their shares.
The current stock price is around $29.68, reflecting a recent increase in market interest and potential for growth as the sports betting market expands.
Analysts project an earnings per share (EPS) of 0.6 for the current fiscal year, indicating expectations of profitability and financial health moving forward.

DraftKings
Bear Case

Investors should be bearish about investing in DraftKings Inc. for these reasons:

Insider selling activity has been notable, with significant shares sold recently, which may raise concerns about the company's future performance and insider confidence.
Despite the growth potential, the company faces intense competition in the digital gaming space, which could impact its market share and profitability.
Insiders have sold a total of 97,596 shares valued at approximately $2.76 million over the last three months, indicating potential volatility in stock performance.
The company’s reliance on regulatory changes in the U.S. for sports betting could pose risks, as any unfavorable legislation could impact operations and growth.
While the projected EPS is positive, it is essential to consider that earnings projections can change based on market conditions and company performance, which may lead to investor uncertainty.

DKNG Forecast - Frequently Asked Questions

According to the research reports of 40 Wall Street equities research analysts, the average twelve-month stock price forecast for DraftKings is $34.24, with a high forecast of $50.00 and a low forecast of $20.00.

40 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DraftKings in the last twelve months. There are currently 2 sell ratings, 8 hold ratings, 29 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DKNG shares.

According to analysts, DraftKings's stock has a predicted upside of 32.25% based on their 12-month stock forecasts.

Over the previous 90 days, DraftKings's stock had 7 upgrades and 4 downgrades by analysts.

DraftKings has been rated by research analysts at Barclays, Benchmark, BNP Paribas Exane, BTIG Research, Citigroup, Citizens Jmp, Deutsche Bank Aktiengesellschaft, Freedom Capital, Guggenheim, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Moffett Nathanson, Morgan Stanley, Needham & Company LLC, New Street Research, Northland Securities, Raymond James Financial, Roth Mkm, Sanford C. Bernstein, Scotiabank, Stephens, Susquehanna, TD Cowen, Truist Financial, UBS Group, Wedbush, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like DraftKings more than other "consumer discretionary" companies. The consensus rating for DraftKings is Moderate Buy while the average consensus rating for "consumer discretionary" companies is Hold. Learn more on how DKNG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With DraftKings Recommendations

This page (NASDAQ:DKNG) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DraftKings (DKNG) Stock Forecast & Price Target